Aurora Cannabis Inc.

Equities

ACB

CA05156X8504

Pharmaceuticals

Delayed Toronto S.E. 09:59:38 2024-07-22 am EDT 5-day change 1st Jan Change
7.98 CAD +1.27% Intraday chart for Aurora Cannabis Inc. -4.09% +22.77%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss MT
Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats DJ
Transcript : Aurora Cannabis Inc., 2024 Earnings Call, Jun 20, 2024
Aurora Cannabis Trims Q4 Net Loss MT
Aurora Cannabis Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Aurora Cannabis Brief: Re-Affirming Target of Reaching Positive Free Cash Flow by December 31, 2024 MT
Aurora Cannabis Brief: Says Q4 Represents Sixth Consecutive Quarter of Positive Adjusted EBITDA; Adds Ended Fiscal Year with a Cash Position of Near $180 Million with Cannabis Business Debt-Free MT
Aurora Cannabis Brief: Q4 Revenues $67.4 million Vs Forecast As Per Capital IQ of $69.54 Million and Last Year $64.03 Million MT
Aurora Cannabis Inc. Provides Consolidated Earnings Guidance for the First Quarter Ending June 30, 2024 CI
Aurora Cannabis Introduces Resin Cartridges in Australia MT
Aurora Cannabis Brief: Unveiling Premium Resin Cartridges in Australia MT
US Government Reclassifies Marijuana to Less-Restrictive Category MT
Justice Department Set to Post Cannabis Reclassification Plans MT
Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors CI
Aurora Cannabis Inc. Marks First Shipment of Medical Cannabis to the New Zealand Market CI
Aurora Cannabis Brief: Up 0.3% In US Premarket As Marks First Shipment of Medical Cannabis to the New Zealand Market MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup DJ
TSX Down More Than 1% Today and More Than 2% For April, Having Hit Record Highs Earlier In the Month; But Cannabis Stocks Hit a High MT
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug MT
DEA to Move to Reclassify Marijuana, Associated Press Reports MT
Aurora Cannabis Up 0.15% In US Premarket As Expands Offerings in Australia with New Range of Premium Dried Flower Products MT
Aurora Cannabis Brief: Expanding Offerings in Australia with New Range of Premium Dried Flower Products MT
Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products CI
Chart Aurora Cannabis Inc.
More charts
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
7.88 CAD
Average target price
8.779 CAD
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Equities
  3. ACB Stock
  4. News Aurora Cannabis Inc.
  5. Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss